Estimands in clinical drug development: from design to regulatory assessment

In this thesis, I investigated the (implicit) use of estimands in the pre-estimand era in clinical trials for regulatory evaluation and approval to understand what estimands may correspond to efficacy investigations and common efficacy analyses. Additionally, I developed data-generating models (DGMs) that take into account the association between clinical outcomes and intercurrent events.